Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $6
TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $10
Robust Market Potential and Strategic Positioning Drive Optimistic Buy Rating for Geron
H.C. Wainwright Maintains Geron(GERN.US) With Buy Rating, Raises Target Price to $9
H.C. Wainwright Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $8
Geron Analyst Ratings
H.C. Wainwright Initiates Geron(GERN.US) With Buy Rating, Announces Target Price $8
Leerink Partners Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $7
Geron Analyst Ratings
Scotiabank Initiates Geron at Sector Outperform With $6 Price Target
Leerink Partners Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $7
Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9
Goldman Sachs Maintains Geron(GERN.US) With Buy Rating, Announces Target Price $6
Buy Rating on Geron Corp: Rytelo's Reimbursement and Market Adoption Promise Peak Sales
Goldman Sachs Maintains Geron(GERN.US) With Buy Rating
Goldman Sachs Reaffirms Their Buy Rating on Geron (GERN)
Geron Analyst Ratings
Leerink Partners Initiates Geron(GERN.US) With Buy Rating, Announces Target Price $7
Geron Analyst Ratings
Needham Reiterates Buy on Geron, Maintains $6 Price Target